A pharmaceutical error can wipe out a generation of people, so there is need for government to sanction producers of counterfeit malaria drugs. - Catherine Falade

RTS, S/AS01 is being assessed as a complementary malaria control tool that could potentially be added to and not replace the core package of proven malaria preventive, diagnostic and treatment measures.

The vaccines only reduce the risks of malaria by 35 per cent; it does not prevent malaria like other vaccines that babies take at birth for prevention of communicable diseases.

In October 2015, two independent WHO advisory groups recommended the pilot implementation of RTS, S/ASO1 in parts of three to five sub-Saharan African countries.